Skip to content
Delayed ~15 min

FENC FENNEC PHARMACEUTICALS

Health Care · Russell 2000

Next earnings: Thu 12 Nov 2026 · estimated

What 8 analyst firms say about FENNEC PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works

9.81 USD+0.42 (+4.47%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+80.1%to the avg target 17.67 USD+7.86 USD
Buy 6 · Hold 1 · Sell 0

7 rated views · 8 analyst/firm records · 8 firms

Latest report9 Sep 2026avg report date 17 Aug
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8079
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8063

Recent analyst activity · last 90 days

Our tracked history has 8 reports on FENC from 7 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 4 left it unchanged and 2 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Wedbush raised its target from $13.00 (set 16 Apr 2026) to $16.00 on 11 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
B Riley SecuritiesMadison El-SaadiBuy12 Aug 202618.00 USD
Craig-HallumChase KnickerbockerBuy12 Aug 202618.00 USD
H.C. WainwrightRaghuram SelvarajuBuy9 Sep 202616.00 USD
Maxim GroupJason MccarthyBuy13 Aug 202620.00 USD
Piper SandlerDavid AmsellemBuy11 Aug 202618.00 USD
WedbushDavid NierengartenBuy12 Aug 202616.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
Data feed RESEARCHResearch TeamHold25 May 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 07:02 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.